Price range
All prices
Market cap
All caps
Gain
Companies 0
Ratios & returns
Size
Earnings
Valuation
Profitability
Leverage
Quarter
Returns
Biotechnology — 6 companies (standalone), sorted by market cap.
weaker → stronger
SymbolANTHEMADVENZYMESGENESISVIVOBIOTSHREEGANESGVBL
CompanyAnthem Biosciences LtdAdvanced Enzyme Technologies LimitedGenesis Ibrc India LtdVivo Bio Tech LtdShree Ganesh Biotech (India) LtdGenomic Valley Biotech Ltd
LTP92928836.4516.710.4828.73
Gain——————
52W
Market cap₹ cr52,3103,223164.937.119.18.8
TTM revenue₹ cr1,935444.30.054.35.00.2
TTM PAT₹ cr624.280.2-0.9-3.1-0.40.0
Equity₹ cr112.3—————
Price₹92928836.4516.710.4828.73
TTM EPS₹11.127.16-0.50-1.550.000.06
Annual EPS₹11.9511.78-0.53-0.930.010.10
Trailing P/E77.7×24.4×-68.8×-18.0×48.0×287.3×
TTM P/E83.5×40.2×-72.9×-10.8×—478.8×
Forward P/E91.9×36.1×-60.8×-6.3×11.9×431.0×
PEG4.303.11-5.342.20—0.96
P/BV17.201.500.850.172.5614.32
Book value₹53.9819242.8898.290.192.01
ROE20.5%—————
ROCE27.0%—————
OPMJun-2624.7%18.9%0.0%1.3%-40.1%39.5%
Net margin32.3%18.1%—-5.8%-7.8%9.1%
Total debt₹ cr53.90.00.00.00.00.0
Debt / Equity0.02—————
RevenueJun-26383.8115.90.014.11.40.0
RevenueMar-26582.5116.40.013.82.10.0
PATJun-26102.022.4-0.30.2-0.60.0
PATMar-26211.722.3-0.5-5.4-0.20.0
OPMMar-2632.9%18.3%0.0%-39.5%-7.0%-21.1%
1D+0.1%-0.1%+5.0%-1.7%+4.4%-5.0%
1W-1.3%-1.9%+21.5%-0.5%-2.0%-8.8%
1M+4.2%-5.0%-38.8%-12.6%-5.9%-2.6%
3M+24.7%-22.9%-67.8%-30.5%-18.6%-6.9%
1Y+8.6%—-35.1%-57.2%-39.2%-22.9%
3Y——+224.3%-52.8%-47.3%+24.9%